# The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder

> **NCT01822288** · PHASE4 · COMPLETED · sponsor: **Far Eastern Memorial Hospital** · enrollment: 125 (actual)

## Conditions studied

- Menopausal Syndromes

## Interventions

- **DRUG:** Tibolone
- **DRUG:** Estradiol & medroxyprogesterone acetate

## Key facts

- **NCT ID:** NCT01822288
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-16
- **Primary completion:** 2021-07-08
- **Final completion:** 2021-08-26
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2022-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01822288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01822288, "The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01822288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*